Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes
Open accessAbstract
Drug induced liver injury (DILI), a major cause of pre- and post-approval failure, is challenging to predict pre-clinically due to varied underlying direct and indirect mechanisms. Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) and Ritonavir, a protease inhibitor, are antiviral drugs that cause clinical DILI with different phenotypes via different mechanisms. Assessing DILI in vitro in hepatocyte cultures typically requires drug exposures significantly higher than clinical plasma Cmax concentrations, making clinical interpretations of mechanistic pathway changes challenging. We previously described a system that uses liver-derived hemodynamic blood flow and transport parameters to restore primary human hepatocyte biology, and drug responses at concentrations relevant to in vivo or clinical exposure levels. Using this system, primary hepatocytes from 5 human donors were exposed to concentrations approximating clinical therapeutic and supra-therapeutic levels of Nevirapine (11.3 and 175.0 μM) and Ritonavir (3.5 and 62.4 μM) for 48 h. Whole genome transcriptomics was performed by RNAseq along with functional assays for metabolic activity and function. We observed effects at both doses, but a greater number of genes were differentially expressed with higher probability at the toxic concentrations. At the toxic doses, both drugs showed direct cholestatic potential with Nevirapine increasing bile synthesis and Ritonavir inhibiting bile acid transport. Clear differences in antigen presentation were noted, with marked activation of MHC Class I by Nevirapine and suppression by Ritonavir. This suggests CD8+ T cell involvement for Nevirapine and possibly NK Killer cells for Ritonavir. Both compounds induced several drug metabolizing genes (including CYP2B6, CYP3A4 and UGT1A1), mediated by CAR activation in Nevirapine and PXR in Ritonavir. Unlike Ritonavir, Nevirapine did not increase fatty acid synthesis or activate the respiratory electron chain with simultaneous mitochondrial uncoupling supporting clinical reports of a lower propensity for steatosis. This in vitro study offers insights into the disparate direct and immune-mediated toxicity mechanisms underlying Nevirapine and Ritonavir toxicity in the clinic.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Applying liver sinusoidal hemodynamics and interstitial fluid transport parameters restores a mature, differentiated, in vivo hepatocyte phenotype and function.
“We previously described an approach that applies liver sinusoidal hemodynamics and interstitial fluid transport parameters to restore a mature, differentiated, in vivo hepatocyte phenotype and function”
From Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,480 · see citing works
Mediators of endoplasmic reticulum stress-induced apoptosis
Szegezdi, E., Logue, S. E., Gorman, A. M., & Samali, A. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400779 · Cited by 2,345 · see citing works
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940 · see citing works
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · see citing works
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · see citing works
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E. M., Dahan, K., Childs, S. J., Ling, V. W. T., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995 · see citing works
The Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 972 · see citing works
Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3
Brand, M. D., & Esteves, T. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.002 · Cited by 785 · see citing works
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 550 · see citing works
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 504 · see citing works
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477 · see citing works
Mitochondrial Targets of Drug Toxicity
Wallace, K. B., & Starkov, A. A. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.353 · Cited by 464 · see citing works
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
Cui, J., Zhu, L., Xia, X., Wang, H. Y., Legras, X. D., Hong, J. K., Ji, J., Shen, P., Zheng, S. S., Chen, Z. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.040 · Cited by 449 · see citing works
Luo, G., Cunningham, M. R., Kim, S. T., Burn, T. C., Lin, J., Sinz, M., Hamilton, G. A., Rizzo, C. J., Jolley, S. L., Gilbert, D., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.795 · Cited by 442 · see citing works
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420 · see citing works
Song, K., Li, T., Owsley, E., Strom, S. C., & Chiang, J. Y. L. (2008) · Hepatology · doi:10.1002/hep.22627 · Cited by 414 · see citing works
Acute Liver Failure in the United States
Lee, W. M. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-42641 · Cited by 388 · see citing works
Eagling, V. A., Back, D. J., & Barry, M. G. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00644.x · Cited by 336 · see citing works
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 320 · see citing works
Boess, F. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg064 · Cited by 302 · see citing works
Faucette, S. R., Zhang, T.-C., Moore, R., Sueyoshi, T., Omiecinski, C. J., LeCluyse, E. L., Negishi, M., & Wang, H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112136 · Cited by 294 · see citing works
André, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth, B. L., Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M., & Lotteau, V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13120 · Cited by 279 · see citing works
Kostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262 · see citing works
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Staudinger, J. L., Liu, Y., Madan, A., Habeebu, S. S., & Klaassen, C. D. (2001) · PubMed · Cited by 260 · see citing works
Riddle, T. M., Kuhel, D. G., Woollett, L. A., Fichtenbaum, C. J., & Hui, D. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104557200 · Cited by 216 · see citing works
Farid, W. R. R., Pan, Q., van der Meer, A. J. P., de Ruiter, P. E., Ramakrishnaiah, V., de Jonge, J., Kwekkeboom, J., Janssen, H. L. A., Metselaar, H. J., Tilanus, H. W., et al. (2011) · Liver Transplantation · doi:10.1002/lt.22438 · Cited by 211 · see citing works
Ware, B. R., Berger, D. R., & Khetani, S. R. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv048 · Cited by 196 · see citing works
Recognizing Drug-Induced Liver Injury: Current Problems, Possible Solutions
Lee, W. M., & Senior, J. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522356 · Cited by 189 · see citing works
Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects
Hsu, A., Granneman, G. R., Witt, G. F., Locke, C., Denissen, J. F., Molla, A., Valdes, J. M., Smith, J., Erdman, K. A., Lyons, N., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.898 · Cited by 185 · see citing works
Fromenty, B., Fisch, C., Labbe, G., Degott, C., Deschamps, D., Berson, A., Lettéron, P., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22984-6 · Cited by 178 · see citing works
Hastings, N. E., Simmers, M. B., McDonald, O. G., Wamhoff, B. R., & Blackman, B. R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2007 · Cited by 174 · see citing works
Self-citationDrug-induced mitochondrial toxicity
Chan, K., Truong, D., Shangari, N., & O'Brien, P. J. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.655 · Cited by 173 · see citing works
Safety of Newly Approved Drugs
Temple, R. J., & Himmel, M. H. (2002) · JAMA · doi:10.1001/jama.287.17.2273 · Cited by 172 · see citing works
NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells
Staehli, F., Ludigs, K., Heinz, L. X., Seguín-Estévez, Q., Ferrero, I., Braun, M., Schroder, K., Rebsamen, M., Tardivel, A., Mattmann, C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102671 · Cited by 154 · see citing works
Hoffmaster, K. A., Turncliff, R. Z., LeCluyse, E. L., Kim, R. B., Meier, P. J., & Brouwer, K. L. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033018.97745.0d · Cited by 154 · see citing works
Chai, X., Zeng, S., & Xie, W. L. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.754010 · Cited by 154 · see citing works
Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes
Baker, T. K., Carfagna, M. A., Gao, H. T., Dow, E. R., Li, Q. S., Searfoss, G. H., & Ryan, T. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx015518a · Cited by 143 · see citing works
Caron, M., Auclair, M., Vissian, A., Vigouroux, C., & Capeau, J. (2008) · Antiviral Therapy · doi:10.1177/135965350801300103 · Cited by 114 · see citing works
Carr, D. F., Chaponda, M., Jorgensen, A., Castro, E. M. C., van Oosterhout, J. J., Khoo, S., Lalloo, D. G., Heyderman, R. S., Alfirevic, A., & Pirmohamed, M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit021 · Cited by 109 · see citing works
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., & Wamhoff, B. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2012 · Cited by 108 · see citing works
Self-citationZhou, H., Pandak, W. M., Lyall, V., Natarajan, R., & Hylemon, P. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012898 · Cited by 106 · see citing works
Parker, R. A., Flint, O. P., Mulvey, R., Elosua, C., Wang, F., Fenderson, W., Wang, S., Yang, W.-P., & Noor, M. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010165 · Cited by 104 · see citing works
Flint, O. P., Noor, M. A., Hruz, P. W., Hylemon, P. B., Yarasheski, K. E., Kotler, D. P., Parker, R. A., & Bellamine, A. (2009) · Toxicologic Pathology · doi:10.1177/0192623308327119 · Cited by 101 · see citing works
Zhou, H., Gurley, E. C., Brimson, S. J., Ding, H., Fang, Y., Xu, Z., Pandak, W. M., & Hylemon, P. B. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00182.2006 · Cited by 101 · see citing works
McRae, M. P., Lowe, C. M., Tian, X., Bourdet, D. L., Ho, R. H., Leake, B. F., Kim, R. B., Brouwer, K. L. R., & Kashuba, A. D. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102657 · Cited by 98 · see citing works
Dissecting Cytochrome P450 3A4–Ligand Interactions Using Ritonavir Analogues
Sevrioukova, I. F., & Poulos, T. L. (2013) · Biochemistry · doi:10.1021/bi4005396 · Cited by 92 · see citing works
Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors
Sulkowski, M. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39949 · Cited by 87 · see citing works
Cheng, J., Fang, Z., Kim, J. H., Krausz, K. W., Tanaka, N., Chiang, J. Y. L., & Gonzalez, F. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m044420 · Cited by 71 · see citing works
Sterling, R. K., Contos, M. J., Smith, P. G., Stravitz, R. T., Luketic, V. A., Fuchs, M. A., Shiffman, M. L., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22134 · Cited by 69 · see citing works
A new era of antiretroviral drug toxicity
Calmy, A., Hirschel, B. J., Cooper, D. A., & Carr, A. D. (2008) · Antiviral Therapy · doi:10.1177/135965350901400203 · Cited by 64 · see citing works
Simulating Microdosimetry in a Virtual Hepatic Lobule
Wambaugh, J., & Shah, I. (2010) · PLoS Comput. Biol. · doi:10.1371/journal.pcbi.1000756 · Cited by 63 · see citing works
Keane, N. M., Pavlos, R. K., McKinnon, E., Lucas, A., Rive, C. M., Blyth, C. C., Dunn, D., Lucas, M., Mallal, S. A., & Phillips, E. J. (2014) · AIDS · doi:10.1097/qad.0000000000000345 · Cited by 61 · see citing works
Hastings, N. E., Feaver, R. E., Lee, M. Y., Wamhoff, B. R., & Blackman, B. R. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.184382 · Cited by 57 · see citing works
Self-citationRegulation of Hepatic Drug Metabolism: Role of the Nuclear Receptors PXR and CAR
Liddle, C., & Goodwin, B. J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30098 · Cited by 54 · see citing works
Nevirapine toxicity in a cohort of HIV-1–infected pregnant women
Joao, E. C., Calvet, G. A., de Menezes, J. A., D'Ippolito, M., Cruz, M. L. S., Salgado, L. A. T., & de Matos, H. J. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.015 · Cited by 49 · see citing works
Negredo, E., Miró, Ò., Rodríguez‐Santiago, B., Garrabou, G., Estany, C., Masabeu, À., Force, L., Barrufet, P., Cucurull, J., Domingo, P., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605440 · Cited by 48 · see citing works
Ulianich, L., Terrazzano, G., Annunziatella, M., Ruggiero, G., Bèguinot, F., & Jeso, B. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.013 · Cited by 45 · see citing works
Once‐daily nevirapine dosing: a pharmacokinetics, efficacy and safety review
Cooper, C., & Heeswijk, R. G. V. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00426.x · Cited by 44 · see citing works
MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity
Kia, R., Kelly, L., Sison-Young, R. L. C., Zhang, F., Pridgeon, C. S., Heslop, J. A., Metcalfe, P., Kitteringham, N. R., Baxter, M. A., Harrison, S. P., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu269 · Cited by 41 · see citing works
How useful are clinical liver function tests in in vitro human hepatotoxicity assays?
Borlak, J. T., Chougule, A., & Singh, P. K. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.03.006 · Cited by 37 · see citing works
Nuclear Receptors in Acute and Chronic Cholestasis
Gonzalez‐Sanchez, E., Firrincieli, D., Housset, C., & Chignard, N. (2015) · Digestive Diseases · doi:10.1159/000371688 · Cited by 36 · see citing works
Chen, J., & Farrell, G. C. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00095.x · Cited by 36 · see citing works
Halladay, J. S., Wong, S., Khojasteh, S. C., & Grepper, S. (2012) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2012.07.004 · Cited by 34 · see citing works
Distribution of pressure gradients along hepatic vasculature
Maass‐Moreno, R., & Rothe, C. F. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.6.h2826 · Cited by 28 · see citing works
Nelson, L. J., Treskes, P., Howie, A. F., Walker, S. W., Hayes, P. C., & Plevris, J. N. (2013) · Scientific Reports · doi:10.1038/srep02735 · Cited by 26 · see citing works
Zhang, Z., Li, X., Liu, G., Gao, L., Guo, C., Kong, T., Wang, H., Gao, R., Wang, Z., & Zhu, X. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000330072 · Cited by 22 · see citing works
Organotypic systems in drug metabolism and toxicity: challenges and opportunities
Dash, A., Blackman, B. R., & Wamhoff, B. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.693161 · Cited by 21 · see citing works
Self-citationPopović, M., Shenton, J. M., Chen, J., Baban, A., Tharmanathan, T., Mannargudi, B. M., Abdulla, D., & Uetrecht, J. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_15 · Cited by 21 · see citing works
Lum, P. Y., He, Y. D., Slatter, J. G., Waring, J. F., Zelinsky, N., Cavet, G., Dai, X., Fong, O., Gum, R. J., Jin, L., et al. (2007) · Genomics · doi:10.1016/j.ygeno.2007.06.004 · Cited by 20 · see citing works
Inflammation et métabolisme des médicaments
Pascussi, J., & Vilarem, M. (2008) · médecine/sciences · doi:10.1051/medsci/2008243301 · Cited by 13 · see citing works
Fang, J., & Beland, F. A. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.741 · Cited by 13 · see citing works
Cole, B. K., Simmers, M. B., Feaver, R. E., Qualls, C. W., Collado, M. S., Berzin, E., Figler, R. A., Pryor, A. W., Lawson, M. J., Mackey, A. J., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306245 · Cited by 9 · see citing works
Self-citationα-Glutathione-s-transferase as a new sensitive marker of hepatocellular damage in biliary atresia
Kobayashi, H., Horikoshi, K., Yamataka, A., Lane, G. J., Watanabe, S., Futagawa, S., & Miyano, T. (2000) · Pediatric Surgery International · doi:10.1007/s003830050749 · Cited by 7 · see citing works
New black box warning for ritonavir-boosted tipranavir.
Ryan, C. T. (2006) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hu, L., Chen, S., Fu, Y., Gao, Z., Long, H., Ren, H., Zuo, Y., Li, H., Wang, J., Yu, W.-X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa539 · Cited by 398 · see citing works
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Feaver, R. E., Cole, B. K., Lawson, M. J., Hoang, S. A., Marukian, S., Blackman, B. R., Figler, R. A., Sanyal, A. J., Wamhoff, B. R., & Dash, A. (2016) · JCI Insight · doi:10.1172/jci.insight.90954 · Cited by 153 · see citing works
Self-citationHuman biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117 · see citing works
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
Cole, B. K., Feaver, R. E., Wamhoff, B. R., & Dash, A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1410135 · Cited by 79 · see citing works
Self-citationDash, A., Figler, R. A., Sanyal, A. J., & Wamhoff, B. R. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1246534 · Cited by 60 · see citing works
Self-citationNNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
Benedicto, A. M., Fuster‐Martínez, I., Tosca-Cuquerella, J., Esplugues, J. V., Blas‐García, A., & Apostolova, N. (2021) · Cells · doi:10.3390/cells10071687 · Cited by 51 · see citing works
Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
Mosedale, M., & Watkins, P. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01297 · Cited by 52 · see citing works
Collado, M. S., Cole, B. K., Figler, R. A., Lawson, M. J., Manka, D. R., Simmers, M. B., Hoang, S. A., Serrano, F., Blackman, B. R., Sinha, S., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0004 · Cited by 42 · see citing works
Self-citationThe Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
Sernoskie, S. C., Jee, A., & Uetrecht, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000090 · Cited by 41 · see citing works
Sistare, F. D., Mattes, W. B., & LeCluyse, E. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw025 · Cited by 39 · see citing works
Dash, A., Figler, R. A., Blackman, B., Marukian, S., Collado, M. S., Lawson, M. J., Hoang, S. A., Mackey, A. J., Manka, D. R., Cole, B. K., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.11.014 · Cited by 36 · see citing works
Self-citationPXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches
Wang, J., Bwayi, M. N., Gee, R. R. F., & Chen, T. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1779701 · Cited by 31 · see citing works
Friman, T., Chernobrovkin, A. L., Molina, D. M., & Arnold, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220973597 · Cited by 25 · see citing works
Current insights in the complexities underlying drug-induced cholestasis
Deferm, N., Vocht, T. D., Qi, B., Brantegem, P. V., Gijbels, E., Vinken, M., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1635081 · Cited by 24 · see citing works
Leslie, J., Krishnamurthy, K. A., Gopalsamy, I. K., Inácio, P., Huch, M., Gallage, S., Oakley, F., & Vacca, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01162-9 · Cited by 25 · see citing works
Chapman, K. A., Collado, M. S., Figler, R. A., Hoang, S. A., Armstrong, A. J., Cui, W., Purdy, M. D., Simmers, M. B., Yazigi, N. A., Summar, M. L., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.12.008 · Cited by 19 · see citing works
Self-citationCipriano, M., Pinheiro, P. F., Sequeira, C. O., Rodrigues, J. S., Oliveira, N., Antunes, A. M. M., Castro, M., Marques, M. M., Pereira, S. A., & Miranda, J. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113998 · Cited by 16 · see citing works
Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology
Sonderup, M. W., & Wainwright, H. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.007 · Cited by 16 · see citing works
Systems biology for organotypic cell cultures
Grego, S. (2016) · ALTEX · doi:10.14573/altex.1608221 · Cited by 15 · see citing works
Han, C., Cui, Y., Guo, Y., Zhang, D., Wang, X., Geng, Y., Shi, W., & Bao, Y. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101228 · Cited by 14 · see citing works
Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment
Gruevska, A., Moragrega, Á. B., Cossarizza, A., Esplugues, J. V., Blas‐García, A., & Apostolova, N. (2021) · Cells · doi:10.3390/cells10020410 · Cited by 14 · see citing works
Gao, Q.-C., Liu, G.-L., Wang, Q., Zhang, S., Ji, Z., Wang, Z., Wu, M., Yu, Q., & He, P. F. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103420 · Cited by 11 · see citing works
A scalable human liver-on-a-chip platform for predictive safety assessment
Kulkarni, G., Chen, L., Sang, J., Seo, J. H., Grall, R., Wang, Y., Gilbride, P., Yuan, Y., Albaum-Getzen, M., McCormack, J., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154378 · Cited by 9 · see citing works
The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury
Jee, A., Sernoskie, S. C., & Uetrecht, J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae054 · Cited by 6 · see citing works
Physiologically relevant microsystems to study viral infection in the human liver
McDuffie, D., Barr, D., Agarwal, A., & Thomas, E. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999366 · Cited by 4 · see citing works
Bajaj, P., Brennan, R., Laurent, S., Sauzeat, S., Dufault, M. R., Richards, B., & Adkins, K. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf012 · Cited by 4 · see citing works
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2 · see citing works
Dash, A., & Proctor, W. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00006-2 · Cited by 2 · see citing works
Self-citationHuman cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
Feaver, R. E., Bowers, M. S., Cole, B. K., Hoang, S. A., Lawson, M. J., Taylor, J. M., LaMoreaux, B. D., Zhao, L., Henke, B. R., Johns, B. A., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291330 · Cited by 2 · see citing works
Self-citationMechanisms of Drug‐induced Liver Injury
Watkins, P. B., & Mosedale, M. (2017) · doi:10.1002/9781119251316.ch28 · Cited by 2 · see citing works
Langat, R., McRaven, M. D., Lorenzo-Redondo, R., Muhomah, T., Carias, A. M., Arif, M. S., Akiso, M., Mureithi, M., Anzala, O., Gilmour, J. W., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334510 · Cited by 1 · see citing works
Han, W., & Duan, Z. (2019) · Toxin Reviews · doi:10.1080/15569543.2019.1639060 · Cited by 1 · see citing works
Editorial: Promising approaches to identify DILI drugs
Li, A. P., & Zhang, J. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.021 · Cited by 1 · see citing works
- Authors
- Terelius, Y., Figler, R. A., Marukian, S., Collado, M. S., Lawson, M. J., Mackey, A. J., Manka, D., Qualls, C. W., Blackman, B. R., Wamhoff, B. R., & Dash, A.
- Affiliations
- Medivir (Sweden) (SE)
- HemoShear (United States) (US)
- Corresponding author
- Dash, Ajit
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 255
- Pages
- 31-44
- ISSN
- 0009-2797 (ISSN-L)
- PMC
- PMC4889565
- OpenAlex
- W2183384736
- Cited by
- 33
- References
- 74
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 6 · 2015: 1
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemico-Biological Interactions (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH
- NIDDK (R44 DK091104)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- drug-induced liver injury, nevirapine, ritonavir, hepatotoxicity mechanisms, primary human hepatocytes, cholestasis, bile acid transport, MHC class I antigen presentation, CD8+ T cells, natural killer cells, drug-metabolizing enzymes, CYP2B6, CYP3A4, UGT1A1, mitochondrial uncoupling, steatosis, antiretroviral drugs, transcriptomics
- MeSH terms
- Cells, Cultured, Drug Evaluation, Preclinical, Humans, Liver, Cell Culture Techniques, Anti-HIV Agents, Ritonavir, Nevirapine, Hepatocytes, Chemical and Drug Induced Liver Injury, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
